LMF
GYRE icon

LMR Master Fund’s Gyre Therapeutics GYRE Stock Holding History

LMR Master Fund’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$69K Buy
+21
New +$82.8K 0.01% 333

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LMR Master Fund's GYRE Position: Q4 2013 in Review

LMR Master Fund opened a new position in Gyre Therapeutics (GYRE) in Q4 2013: 21 shares worth $69K. The stake represents 0.01% of the portfolio and ranks #333 among its holdings.

74 funds tracked by Wall St. Rank hold GYRE as of Q4 2013.

  • LMR Master Fund held 21 shares of Gyre Therapeutics worth $69K as of Q4 2013.
  • Gyre Therapeutics was a new LMR Master Fund position in Q4 2013.
  • Gyre Therapeutics made up 0.01% of LMR Master Fund's portfolio in Q4 2013, its #333 holding.
  • 74 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.